WallStSmart
OTLK

OUTLOOK THERAPEUTICS INC

NASDAQ: OTLK · HEALTHCARE · BIOTECHNOLOGY

$0.25
-2.50% today

Updated 2026-04-30

Market cap
$34.41M
P/E ratio
P/S ratio
167.29x
EPS (TTM)
$-2.89
Dividend yield
52W range
$0 – $3
Volume
3.6M

OUTLOOK THERAPEUTICS INC (OTLK) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-96.9%
Last 4 quarters
Revenue YoY growth
-810.1%
Most recent quarter
EPS YoY growth
+75.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-13.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-16.4%
2026-02-17
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-17$-0.22-26.9%$0.49$0.41-16.4%
2025-12-19$-0.28-366.7%$2.07$1.84-11.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.17$-0.22-26.9%$-1.21M-810.1%
2025-09-30$-0.06$-0.28-366.7%$-91787.00-154.0%
2025-06-30$-0.06$-0.55-816.7%$1.51M
2025-03-31$-0.55$-0.34+39.2%
2024-12-31$-0.52$-0.89-71.2%$170124.00
2024-09-30$-0.90$-0.94-4.1%$170124.00
2024-06-30$-1.01$-0.83+17.8%
2024-03-31$-0.85$-1.55-82.4%
2023-12-31$-0.05$-0.04+20.0%
2023-09-30$-0.06$-0.05+16.7%
2023-06-30$-0.05$-0.08-60.0%
2023-03-31$-0.06$-0.03+50.0%

Frequently asked questions

Has OUTLOOK THERAPEUTICS INC beaten earnings estimates?
OUTLOOK THERAPEUTICS INC has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -96.9% over the last 4 quarters.
How does OTLK stock react to earnings?
OTLK stock has moved an average of -13.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is OUTLOOK THERAPEUTICS INC's revenue growth rate?
OUTLOOK THERAPEUTICS INC reported year-over-year revenue growth of -810.1% in its most recent quarter, with EPS growing +75.3% year-over-year.